Ephedrine

Chemical formula: C₁₀H₁₅NO Molecular mass: 165.232 g/mol PubChem compound: 9294

Therapeutic indications

Ephedrine is indicated for:

Bronchospasm in asthma

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Ephedrine is indicated for the treatment or prevention of attacks of bronchospasm in asthma.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

45–180 mg in 3 divided doses daily

Hypotension from spinal or epidural anaesthesia

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Reversal of hypotension from spinal or epidural anaesthesia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

3-30 mg

Bronchospasm in asthma

Population group: only children (1 year - 12 years old)

Ephedrine is indicated for the treatment or prevention of attacks of bronchospasm in asthma.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

45–90 mg in 3 divided doses daily

Bronchospasm in asthma

Population group: only elderly (65 years old or older)

Ephedrine is indicated for the treatment or prevention of attacks of bronchospasm in asthma.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

30–90 mg in 3 divided doses daily

Nasal congestion

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

For the relief of nasal congestion.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

4-8 drops in 4 divided doses

Contraindications

Ephedrine is contraindicated in the following cases:

Hypersensitivity to ephedrine

Ephedrine allergy

Νon-selective monoamine oxidase inhibitors (MAOI)

Non selective Monoamine Oxidase Inhibitors

Alpha sympathomimetic agents

Alpha adrenergic agonists

Phenylpropanolamine, phenylephrine, pseudoephedrine, methylphenidate

at least one of

Phenylpropanolamine
Phenylephrine
Pseudoephedrine
Methylphenidate

Thyrotoxicosis

Thyrotoxicosis

Prostatic hypertrophy

Benign prostatic hyperplasia

Hypertension

Hypertension

Ischaemic heart disease

Ischemic heart disease

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈